MedImmune's swelling product pipeline

MedImmune's swelling product pipeline MedImmune Inc. 's decision to buy Melville Biologics, which develops, manufactures and distributes blood-derived products, provides MEDI with an in-house manufactuing facility and could give MEDI up to seven products within two to three years.

"MedImmune's sales reps could end up with seven files in their briefcases instead of two," said Hambrecht & Quist analyst Timothy Wilson. "It will give its sales force an opportunity to sell more products."

Bear Stearns analyst Joseph Ricardo agreed: "By 1995 MedImmune could have 5

Read the full 892 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE